Food and Drug Administration

Posts relating to the United States FDA, Center for Tobacco Products, Tobacco Control Act and Federal tobacco and nicotine policy

Chaos, waste and failure: what is wrong with FDA tobacco regulation, and how could it improve?

This is my response to the operational review of the performance of the FDA’s Center for Tobacco Products by the Reagan-Udall foundation. The heart of the problem is the lack of a coherent regulatory strategy, grounded in real-world understanding

Chaos, waste and failure: what is wrong with FDA tobacco regulation, and how could it improve? Read More

From FDA to PMI – a sell-out or a bold move for public health?

Matt Holman resigns as Director of the Office of Science at the Center for Tobacco Products at the FDA. He is moving to the tobacco company Philip Morris International to be Vice President of US Scientific Engagement & Regulatory Strategy. What to make of this? I write him an open letter.

From FDA to PMI – a sell-out or a bold move for public health? Read More

Twenty reasons to be sceptical about rules lowering nicotine levels in cigarettes – and what to do instead

Using regulation to remove nearly all the nicotine from cigarettes is similar in effect to a prohibition – with all that entails. That will trigger a wide range of responses by consumers and suppliers. These have barely been studied or understood.

Twenty reasons to be sceptical about rules lowering nicotine levels in cigarettes – and what to do instead Read More

Scroll to Top